NCT06844058 Islamic-Oriented vs. Standard Ericksonian Hypnotherapy for Anxiety and Depression
| NCT ID | NCT06844058 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Nisantasi University |
| Condition | Anxiety Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2025-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-01-15 with a primary completion date of 2025-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial (RCT) aims to compare the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in reducing symptoms of anxiety and depression. The study will enroll 90 participants with mild to moderate anxiety and depression, who will be randomly assigned to one of three groups: (1) IEH intervention, (2) SEH intervention, or (3) control group (no intervention). Participants in the intervention groups will receive 12 weekly hypnotherapy sessions, each lasting 60 minutes. The primary outcomes include changes in Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores from baseline to post-intervention and at a 4-week follow-up. The study will also assess whether religious belief levels moderate the effects of the intervention using the OK-Religious Attitude Scale. Data collection will be performed at Istanbul Nişantaşı University, and ethical approval has been obtained.
Eligibility Criteria
Inclusion Criteria: * Muslim individuals aged 18-65 years. * Mild to moderate anxiety and/or depression symptoms (assessed via Beck * Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)). * No formal psychiatric diagnosis but experiencing psychological distress. * High religious belief levels, assessed via OK-Religious Attitude Scale. * Not currently receiving psychotherapy or psychotropic medication. * Ability to give informed consent and complete the study requirements. Exclusion Criteria: * Severe psychiatric disorders (schizophrenia, bipolar disorder, severe MDD). * Current use of psychotropic medication or undergoing psychotherapy. * History of substance abuse or dependence. * Diagnosed dissociative disorders (contraindications for hypnosis). * Cognitive impairment affecting comprehension of intervention. * Severe medical conditions that may interfere with participation.
Contact & Investigator
Metin Çınaroğlu, Phd
PRINCIPAL INVESTIGATOR
Istanbul Nisantasi Universitesi
Frequently Asked Questions
Who can join the NCT06844058 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Anxiety Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06844058 currently recruiting?
Yes, NCT06844058 is actively recruiting participants. Contact the research team at metin.cinaroglu@nisantasi.edu.tr for enrollment information.
Where is the NCT06844058 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06844058 clinical trial?
NCT06844058 is sponsored by Istanbul Nisantasi University. The principal investigator is Metin Çınaroğlu, Phd at Istanbul Nisantasi Universitesi. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.